379 related articles for article (PubMed ID: 23159884)
1. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
2. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
[TBL] [Abstract][Full Text] [Related]
3. Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes.
Otto TC; Harsch CK; Yeung DT; Magliery TJ; Cerasoli DM; Lenz DE
Biochemistry; 2009 Nov; 48(43):10416-22. PubMed ID: 19764813
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of novel catalytic bioscavengers of organophosphorus nerve agents.
Otto TC; Scott JR; Kauffman MA; Hodgins SM; Ditargiani RC; Hughes JH; Sarricks EP; Saturday GA; Hamilton TA; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):186-90. PubMed ID: 23041042
[TBL] [Abstract][Full Text] [Related]
5. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
[TBL] [Abstract][Full Text] [Related]
6. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
[TBL] [Abstract][Full Text] [Related]
7. Engineered Recombinant PON1-OPH Fusion Hybrids: Potentially Effective Catalytic Bioscavengers against Organophosphorus Nerve Agent Analogs.
Lee N; Yun H; Lee C; Lee Y; Kim E; Kim S; Jeon H; Yu C; Rho J
J Microbiol Biotechnol; 2021 Jan; 31(1):144-153. PubMed ID: 33144547
[TBL] [Abstract][Full Text] [Related]
8. Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase.
Yeung DT; Smith JR; Sweeney RE; Lenz DE; Cerasoli DM
FEBS J; 2007 Mar; 274(5):1183-91. PubMed ID: 17286579
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase activity against nerve gases measured by capillary electrophoresis and characterization of human serum paraoxonase (PON1) polymorphism in the coding region (Q192R).
Kanamori-Kataoka M; Seto Y
Anal Biochem; 2009 Feb; 385(1):94-100. PubMed ID: 18952040
[TBL] [Abstract][Full Text] [Related]
10. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
12. Rational design of paraoxonase 1 (PON1) for the efficient hydrolysis of organophosphates.
Le QA; Chang R; Kim YH
Chem Commun (Camb); 2015 Oct; 51(77):14536-9. PubMed ID: 26286433
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
[TBL] [Abstract][Full Text] [Related]
14. An OPAA enzyme mutant with increased catalytic efficiency on the nerve agents sarin, soman, and GP.
Bae SY; Myslinski JM; McMahon LR; Height JJ; Bigley AN; Raushel FM; Harvey SP
Enzyme Microb Technol; 2018 May; 112():65-71. PubMed ID: 29499783
[TBL] [Abstract][Full Text] [Related]
15. Molecular Docking, Metal Substitution and Hydrolysis Reaction of Chiral Substrates of Phosphotriesterase.
de Castro AA; Caetano MS; Silva TC; Mancini DT; Rocha EP; da Cunha EF; Ramalho TC
Comb Chem High Throughput Screen; 2016; 19(4):334-44. PubMed ID: 27012528
[TBL] [Abstract][Full Text] [Related]
16. Assessing protection against OP pesticides and nerve agents provided by wild-type HuPON1 purified from Trichoplusia ni larvae or induced via adenoviral infection.
Hodgins SM; Kasten SA; Harrison J; Otto TC; Oliver ZP; Rezk P; Reeves TE; Chilukuri N; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):177-80. PubMed ID: 23123254
[TBL] [Abstract][Full Text] [Related]
17. In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates.
Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Farag HA; Agrawal P; Doctor BP; Nambiar MP
Toxicol In Vitro; 2011 Jun; 25(4):905-13. PubMed ID: 21382471
[TBL] [Abstract][Full Text] [Related]
18. Rational design of organophosphorus hydrolase with high catalytic efficiency for detoxifying a V-type nerve agent.
Jeong YS; Choi JM; Kyeong HH; Choi JY; Kim EJ; Kim HS
Biochem Biophys Res Commun; 2014 Jul; 449(3):263-7. PubMed ID: 24824182
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Sci; 2013 Dec; 22(12):1799-807. PubMed ID: 24123308
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Biggemann L; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Biochem Pharmacol; 2011 Mar; 81(6):800-9. PubMed ID: 21219877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
